NYSEAMERICAN : MLSS
Milestone Scientific Inc. — Financial statements
Healthcare · Medical Instruments & Supplies · United States
Last price 0.3251 USD (Nov 2, 2026, 4:00 AM EST) · Market cap 28.85M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Milestone Scientific Inc. (MLSS) reported revenue of 9.42M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 9.42M | 8.97M | 8.63M | 9.83M | 8.81M | 10.30M |
| Cost of Revenue | 2.80M | 2.57M | 2.20M | 3.03M | 3.91M | 3.99M |
| Gross Profit | 6.62M | 6.41M | 6.43M | 6.79M | 4.90M | 6.31M |
| Selling, General & Admin | 10.61M | 11.58M | 12.30M | 13.14M | 12.51M | 12.74M |
| Research & Development | 35.17K | 449.47K | 858.77K | 701.38K | 1.15M | 878.21K |
| Operating Expenses | 10.72M | 12.10M | 13.19M | 13.90M | 13.73M | 13.69M |
| Operating Income | -4.10M | -5.70M | -6.76M | -7.11M | -8.83M | -7.38M |
| Interest Expense | -39.93K | -25.60K | -16.36K | |||
| Interest & Investment Income | 60.27K | 125.53K | 54.61K | |||
| Earnings From Equity Investments | 242.59K | |||||
| Other Non Operating Income (Expenses) | 1.98M | |||||
| EBT Excluding Unusual Items | -4.14M | -5.72M | -4.71M | -6.98M | -8.77M | -7.15M |
| Other Unusual Items | 276.18K | |||||
| Pretax Income | -4.14M | -5.72M | -4.71M | -6.98M | -8.77M | -6.88M |
| Income Tax Expense | 333.00 | |||||
| Earnings From Continuing Operations | -4.14M | -5.72M | -4.71M | -6.98M | -8.77M | -6.88M |
| Minority Interest in Earnings | 51.84K | 66.73K | 58.12K | |||
| Net Income | -4.14M | -5.72M | -4.71M | -6.93M | -8.71M | -6.82M |
| Net Income to Common | -4.14M | -5.72M | -4.71M | -6.93M | -8.71M | -6.82M |
| Shares Outstanding (Basic) | 84.81M | 82.06M | 79.79M | 72.78M | 70.61M | 68.83M |
| Shares Outstanding (Diluted) | 84.81M | 82.06M | 79.79M | 72.78M | 70.61M | 68.83M |
| EPS (Basic) | -0.05 | -0.07 | -0.06 | -0.10 | -0.12 | -0.10 |
| EPS (Diluted) | -0.05 | -0.07 | -0.06 | -0.10 | -0.12 | -0.10 |
| Free Cash Flow | -657.76K | -2.93M | -2.93M | -5.33M | -6.04M | -4.05M |
| Free Cash Flow Per Share | -0.01 | -0.04 | -0.04 | -0.07 | -0.09 | -0.06 |
| Gross Margin | 70.23% | 71.40% | 74.56% | 69.12% | 55.65% | 61.25% |
| Operating Margin | -43.56% | -63.48% | -78.30% | -72.31% | -100.25% | -71.60% |
| Profit Margin | -43.98% | -63.77% | -54.62% | -70.51% | -98.87% | -66.17% |
| Free Cash Flow Margin | -6.98% | -32.67% | -33.95% | -54.25% | -68.60% | -39.29% |
| EBITDA | -4.03M | -5.62M | -6.72M | -7.04M | -8.76M | -7.30M |
| EBITDA Margin | -42.73% | -62.61% | -77.86% | -71.68% | -99.52% | -70.89% |
| D&A For EBITDA | 78.30K | 78.19K | 37.45K | 62.32K | 63.84K | 73.83K |
| EBIT | -4.10M | -5.70M | -6.76M | -7.11M | -8.83M | -7.38M |
| EBIT Margin | -43.56% | -63.48% | -78.30% | -72.31% | -100.25% | -71.60% |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.07M | 1.11M | 3.26M | 2.98M | 8.72M | 14.76M |
| Short-Term Investments | 2.98M | |||||
| Cash & Short-Term Investments | 2.07M | 1.11M | 3.26M | 5.95M | 8.72M | 14.76M |
| Accounts Receivable | 1.01M | 706.17K | 475.38K | 312.66K | 693.72K | 943.27K |
| Other Receivables | 40.28K | |||||
| Receivables | 1.05M | 706.17K | 475.38K | 312.66K | 693.72K | 943.27K |
| Inventory | 3.09M | 3.78M | 3.71M | 2.64M | 1.79M | 1.54M |
| Prepaid Expenses | 633.95K | 468.79K | 564.64K | 517.78K | 443.87K | 375.36K |
| Other Current Assets | 1.28M | 1.41M | 1.28M | 1.37M | 1.33M | 1.31M |
| Total Current Assets | 8.12M | 7.48M | 9.29M | 10.79M | 12.97M | 18.93M |
| Property, Plant & Equipment | 161.59K | 225.38K | 337.96K | 374.26K | 479.48K | 574.22K |
| Other Intangible Assets | 44.86K | 79.06K | 148.40K | 178.64K | 227.96K | 277.62K |
| Other Long-Term Assets | 24.15K | 24.15K | 24.15K | 24.15K | 24.15K | 24.15K |
| Total Assets | 8.35M | 7.81M | 9.80M | 11.37M | 13.70M | 19.81M |
| Accounts Payable | 2.86M | 2.79M | 1.51M | 1.10M | 1.91M | 1.18M |
| Accrued Expenses | 1.18M | 1.18M | 2.10M | 1.86M | 1.29M | 1.83M |
| Current Portion of Leases | 136.05K | 157.70K | 128.81K | 113.69K | 101.07K | 89.55K |
| Total Current Liabilities | 4.40M | 4.13M | 3.74M | 3.08M | 3.30M | 3.10M |
| Long-Term Debt | 465.98K | 800.00K | ||||
| Long-Term Leases | 13.67K | 62.54K | 220.25K | 282.29K | 395.98K | 497.04K |
| Total Liabilities | 4.88M | 4.99M | 3.96M | 3.36M | 3.70M | 3.59M |
| Common Stock | 88.77K | 80.49K | 78.05K | 75.88K | 69.31K | 68.15K |
| Additional Paid-In Capital | 139.97M | 137.42M | 134.72M | 132.19M | 127.48M | 124.92M |
| Retained Earnings | -135.67M | -133.78M | -128.05M | -123.34M | -116.41M | -107.70M |
| Treasury Stock | -911.52K | -911.52K | -911.52K | -911.52K | -911.52K | -911.52K |
| Total Common Equity | 3.47M | 2.81M | 5.83M | 8.01M | 10.23M | 16.37M |
| Minority Interest | -219.28K | -152.54K | ||||
| Shareholders' Equity | 3.47M | 2.81M | 5.83M | 8.01M | 10.01M | 16.22M |
| Total Liabilities & Equity | 8.35M | 7.81M | 9.80M | 11.37M | 13.70M | 19.81M |
| Total Debt | 615.70K | 1.02M | 349.05K | 395.98K | 497.04K | 586.59K |
| Net Cash (Debt) | 1.45M | 92.40K | 2.91M | 5.56M | 8.22M | 14.18M |
| Net Cash Per Share | 0.02 | 0.00 | 0.04 | 0.08 | 0.12 | 0.21 |
| Filing Date Shares Outstanding | 88.74M | 80.45M | 78.38M | 76.60M | 70.00M | 68.12M |
| Total Common Shares Outstanding | 88.76M | 80.45M | 78.01M | 75.85M | 69.27M | 68.12M |
| Working Capital | 3.72M | 3.35M | 5.54M | 7.72M | 9.67M | 15.84M |
| Book Value Per Share | 0.04 | 0.03 | 0.07 | 0.11 | 0.15 | 0.24 |
| Tangible Book Value | 3.43M | 2.73M | 5.68M | 7.83M | 10.00M | 16.09M |
| Tangible Book Value Per Share | 0.04 | 0.03 | 0.07 | 0.10 | 0.14 | 0.24 |
| Machinery | 775.97K | 762.55K | 752.44K | 747.56K | 738.95K | |
| Leasehold Improvements | 24.73K | 24.73K | 24.73K | 24.73K | 24.73K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -4.14M | -5.72M | -4.71M | -6.93M | -8.71M | -6.82M |
| Depreciation & Amortization | 186.30K | 185.66K | 134.84K | 150.77K | 144.38K | 147.39K |
| Loss (Gain) From Sale of Investments | -9.28K | |||||
| Loss (Gain) on Equity Investments | -242.59K | |||||
| Stock-Based Compensation | 2.46M | 2.70M | 2.29M | 2.63M | 2.56M | 1.58M |
| Provision & Write-off of Bad Debts | 7.13K | 11.64K | 24.86K | |||
| Other Operating Activities | 206.17K | 515.56K | 373.57K | |||
| Change in Accounts Receivable | -329.20K | -242.43K | -162.71K | 356.19K | 249.56K | 137.38K |
| Change in Inventory | 810.44K | -68.62K | -1.08M | -1.10M | -833.12K | 878.67K |
| Change in Accounts Payable | 905.48K | 1.28M | 414.59K | -806.11K | 729.94K | 308.18K |
| Change in Other Net Operating Assets | -536.06K | -1.06M | 192.15K | 153.31K | -696.09K | -401.96K |
| Operating Cash Flow | -642.64K | -2.92M | -2.92M | -5.33M | -6.03M | -4.03M |
| Capital Expenditures | -15.12K | -15.12K | -10.12K | -4.88K | -8.53K | -15.19K |
| Investment in Securities | 2.98M | -2.97M | ||||
| Investing Cash Flow | -15.12K | -15.12K | 2.97M | -2.97M | -8.53K | -15.19K |
| Long-Term Debt Issued | 800.00K | |||||
| Total Debt Issued | 800.00K | |||||
| Long-Term Debt Repaid | -13.66K | -10.14K | -9.37K | -8.54K | -8.65K | |
| Net Debt Issued (Repaid) | -14.81K | 786.34K | -10.14K | -9.37K | -8.54K | -8.65K |
| Issuance of Common Stock | 1.80M | 243.91K | 2.57M | 4.60M | ||
| Other Financing Activities | -332.67K | |||||
| Financing Cash Flow | 1.45M | 786.34K | 233.77K | 2.56M | -8.54K | 4.59M |
| Net Cash Flow | 792.46K | -2.15M | 280.35K | -5.74M | -6.05M | 540.43K |
| Free Cash Flow | -657.76K | -2.93M | -2.93M | -5.33M | -6.04M | -4.05M |
| Free Cash Flow Margin | -6.98% | -32.67% | -33.95% | -54.25% | -68.60% | -39.29% |
| Free Cash Flow Per Share | -0.01 | -0.04 | -0.04 | -0.07 | -0.09 | -0.06 |
| Levered Free Cash Flow | 981.64K | -682.17K | -2.34M | -1.02M | -3.46M | -1.55M |
| Unlevered Free Cash Flow | 1.01M | -666.17K | -2.34M | -1.02M | -3.46M | -1.54M |
| Change in Working Capital | 850.66K | -93.85K | -631.00K | -1.40M | -549.72K | 922.26K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 28.62M | 21.47M | 74.78M | 52.28M | 33.50M | 139.76M |
| Enterprise Value | 27.17M | 21.17M | 70.31M | 47.83M | 24.00M | 125.74M |
| Last Close Price | 0.32 | 0.27 | 0.96 | 0.69 | 0.48 | 2.06 |
| Forward PE | 20.53 | 20.53 | 20.53 | 20.53 | 20.53 | |
| PS Ratio | 3.04 | 2.39 | 8.66 | 5.32 | 3.80 | 13.56 |
| PB Ratio | 8.25 | 7.63 | 12.82 | 6.53 | 3.35 | 8.62 |
| P/TBV Ratio | 8.35 | 7.85 | 13.15 | 6.67 | 3.35 | 8.69 |
| EV/Sales Ratio | 2.88 | 2.36 | 8.15 | 4.87 | 2.73 | 12.20 |
| Debt / Equity Ratio | 0.18 | 0.36 | 0.06 | 0.05 | 0.05 | 0.04 |
| Net Debt / Equity Ratio | -0.42 | -0.03 | -0.50 | -0.69 | -0.82 | -0.87 |
| Net Debt / EBITDA Ratio | 0.36 | 0.02 | 0.43 | 0.79 | 0.94 | 1.94 |
| Net Debt / FCF Ratio | 2.21 | 0.03 | 0.99 | 1.04 | 1.36 | 3.50 |
| Asset Turnover | 1.15 | 1.02 | 0.81 | 0.78 | 0.53 | 0.52 |
| Inventory Turnover | 0.80 | 0.69 | 0.69 | 1.37 | 2.34 | 2.02 |
| Quick Ratio | 0.71 | 0.44 | 1.00 | 2.04 | 2.85 | 5.07 |
| Current Ratio | 1.85 | 1.81 | 2.48 | 3.51 | 3.93 | 6.11 |
| Return on Equity (ROE) | -121.67% | -132.38% | -68.09% | -77.48% | -66.91% | -42.55% |
| Return on Assets (ROA) | -31.28% | -40.45% | -39.90% | -35.43% | -32.93% | -23.42% |
| Return on Capital Employed (ROCE) | -103.90% | -155.00% | -111.60% | -85.70% | -84.90% | -44.10% |
| Earnings Yield | -15.15% | -26.66% | -6.30% | -13.25% | -25.99% | -4.88% |
| FCF Yield | -2.30% | -13.66% | -3.92% | -10.20% | -18.03% | -2.90% |
| Buyback Yield / Dilution | -5.30% | -2.85% | -9.64% | -3.07% | -2.58% | -9.15% |